{"id":"epicriptine","rwe":[{"pmid":"39017952","year":"2025","title":"Repurposing of FDA-approved drugs against oligomerization domain of dengue virus NS1 protein: a computational approach.","finding":"","journal":"Molecular diversity","studyType":"Clinical Study"},{"pmid":"35832613","year":"2022","title":"Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approaches.","finding":"","journal":"Computational and structural biotechnology journal","studyType":"Clinical Study"}],"tags":[{"label":"epicriptine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Tablet","category":"form"},{"label":"Active","category":"status"},{"label":"Alzheimer's disease","category":"indication"},{"label":"Senile dementia","category":"indication"}],"phase":"marketed","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=EPICRIPTINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:57:09.355178+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:57:14.571246+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EPICRIPTINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:57:14.872182+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2106411/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:57:15.588187+00:00"}},"allNames":"beta-dihydroergocryptine","offLabel":[],"synonyms":["dihydro-beta-ergocryptin","dihydro-beta-ergocryptine","beta-dihydroergocryptine","Dihydro-.beta.-ergocryptine mesylate","epicriptine","Dihydro-.beta.-ergocryptine mesilate"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Beta-Dihydroergocryptine","ecosystem":[{"indication":"Alzheimer's disease","otherDrugs":[{"name":"aducanumab","slug":"aducanumab","company":"Biogen Inc"},{"name":"donepezil","slug":"donepezil","company":"Eisai Inc"},{"name":"galantamine","slug":"galantamine","company":"Janssen Pharms"},{"name":"lecanemab","slug":"lecanemab","company":"Eisai Inc"}],"globalPrevalence":55000000},{"indication":"Senile dementia","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"epicriptine","explanation":"","oneSentence":"","technicalDetail":"Beta-Dihydroergocryptine (EPICRIPTINE) is believed to exert its effects through interaction with dopamine and serotonin receptors, although the exact mechanisms are not fully understood."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4148","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EPICRIPTINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:58:29.965622","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:57:17.264678+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"epicriptine","indications":{"approved":[{"name":"Alzheimer's disease","source":"DrugCentral","snomedId":26929004,"regulator":"FDA","eligibility":"individuals over sixty with idiopathic decline in mental capacity, excluding potentially reversible and treatable conditions such as delirium and dementiform illness secondary to systemic disease, primary neurological disease, or primary disturbance of mood","usPrevalence":6700000,"globalPrevalence":55000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"},{"name":"Senile dementia","source":"DrugCentral","snomedId":15662003,"regulator":"FDA","eligibility":"individuals over sixty with idiopathic decline in mental capacity, excluding potentially reversible and treatable conditions such as delirium and dementiform illness secondary to systemic disease, primary neurological disease, or primary disturbance of mood"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Tablet","formulations":[{"form":"TABLET","route":"ORAL","productName":"Ergoloid Mesylates"}]},"crossReferences":{"UNII":"5M64643B5U","CHEBI":"CHEBI:135927","INN_ID":"6220","RXNORM":"1426905","UMLSCUI":"C3714499","chemblId":"CHEMBL2106411","ChEMBL_ID":"CHEMBL2106411","DRUGBANK_ID":"DB11275","PUBCHEM_CID":"65667","SNOMEDCT_US":"425819004","SECONDARY_CAS_RN":"65914-79-6","MESH_SUPPLEMENTAL_RECORD_UI":"C527876"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[{"date":"2025 Apr","pmid":"39017952","title":"Repurposing of FDA-approved drugs against oligomerization domain of dengue virus NS1 protein: a computational approach.","journal":"Molecular diversity"},{"date":"2022","pmid":"35832613","title":"Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approaches.","journal":"Computational and structural biotechnology journal"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:57:17.264678+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}